Beijing Gene Key Life Technology Co., Ltd
Clinical trials sponsored by Beijing Gene Key Life Technology Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Immune cell therapy takes on untreatable liver cancer Results expected Nov 2026 (estimated)
- Can a new injection boost chemotherapy against pancreatic cancer? Results expected Mar 2027 (estimated)
- Immune cell infusion aims to free ARDS patients from ventilators Results expected Jul 2027 (estimated)